IGG4-RELATED DISEASE
Clinical trials for IGG4-RELATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new IGG4-RELATED DISEASE trials appear
Sign up with your email to follow new studies for IGG4-RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy takes on stubborn autoimmune diseases
Disease control TerminatedThis early study tested a new cell therapy called LUCAR-G79 in just 3 adults with severe autoimmune diseases that did not respond to standard treatments. The therapy uses specially engineered immune cells to target and potentially calm the overactive immune system. The main goals…
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental drug for rare inflammatory disease shows early promise but trial cut short
Disease control TerminatedThis study tested elotuzumab, a drug used for multiple myeloma, in people with active IgG4-related disease (IgG4-RD), a rare condition causing inflammation and organ damage. The trial was small (only 8 participants) and was terminated early, so it is unclear if the drug is safe o…
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC